However, it may also bring in adverse effects, including nausea, constipation, and black stools
Semaglutide demonstrated consistent improvements across multiple noninvasive markers of liver health in the ESSENCE trial
Other gastrointestinal effects to monitor include vomiting, diarrhea, abdominal pain, and constipation
Wegovy injection can be used for: Long-term weight loss and weight management in: adults and patients over 12 years old with obesity, or adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) Reduce the risk of major cardiovascular events such as cardiovascular death, non-fatal myocardial infarction, or nonfatal stroke in: adults with established cardiovascular disease and either obesity or overweight
Each single-patient-use WEGOVY FlexTouch Pen contains additional volume to allow for device priming